γ-Diketone Peripheral Neuropathy: I. Quantitative Morphometric Analyses of Axonal Atrophy and Swelling

Quantitative morphometric analysis was used to characterize expression of myelinated axon swelling and atrophy in rat peripheral nerve during 2,5-hexanedione (HD) intoxication. HD was administered by gavage according to different daily dosing regiments (100, 175, 250, or 400 mg/kg/day) and four prox...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 2000-06, Vol.165 (2), p.127-140
Hauptverfasser: Lehning, Ellen J., Jortner, Bernard S., Fox, Jonathan H., Arezzo, Joseph C., Kitano, Taka-aki, LoPachin, Richard M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 140
container_issue 2
container_start_page 127
container_title Toxicology and applied pharmacology
container_volume 165
creator Lehning, Ellen J.
Jortner, Bernard S.
Fox, Jonathan H.
Arezzo, Joseph C.
Kitano, Taka-aki
LoPachin, Richard M.
description Quantitative morphometric analysis was used to characterize expression of myelinated axon swelling and atrophy in rat peripheral nerve during 2,5-hexanedione (HD) intoxication. HD was administered by gavage according to different daily dosing regiments (100, 175, 250, or 400 mg/kg/day) and four proximodistal nerve regions (5th lumbar spinal nerve, proximal and distal sciatic nerve, and tibial nerve) were examined morphometrically. Morphometric determinations were made at four behavioral endpoints (unaffected, slight, moderate, and severe toxicity) and were correlated to electrophysiologic measurements of peripheral nerve function. Results show that, for all HD dose rates, onsets of behavioral neurotoxicity and nerve dysfunction were generally related to development of abundant axon atrophy. The proximodistal manifestation of atrophy was dependent upon the dosing rate; i.e., the atrophy response produced by subacute intoxication with higher daily dosing rates (250 and 400 mg/kg/day) was restricted to distal nerve regions whereas subchronic induction with lower dosing rates (100 and175 mg/kg/day) produced abundant fiber atrophy in all proximodistal areas. In contrast to atrophy, axonal swellings constituted an inconsistent minor morphologic response, the expression of which was dependent upon subchronic dosing rates (100–250 mg/kg/day). Subacute HD administration (400 mg/kg/day) produced significant changes in neurobehavior and nerve electrophysiologic parameters in the absence of peripheral axon swelling. Thus, conditional expression of swellings suggests they are an epiphenomenon related to low-dose induction rates. Fiber atrophy, however, was numerically dominant, correlated with nerve dysfunction, and occurred at all dosing levels. These characteristics suggest atrophy is a neurotoxicologically significant feature of γ-diketone peripheral neuropathy.
doi_str_mv 10.1006/taap.2000.8937
format Article
fullrecord <record><control><sourceid>elsevier_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_1403058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X00989373</els_id><sourcerecordid>S0041008X00989373</sourcerecordid><originalsourceid>FETCH-LOGICAL-e231t-28eb3439070596757018b74ec29aca100952fa09d6f0e151dfe8611c57e758f53</originalsourceid><addsrcrecordid>eNotkMtOwzAQRS0EEqWwZe0F25RxHCcxu4hnpfISILGzXGfSGNIkctxCvov_4JtIVFajK50Z3TmEnDKYMYD43GvdzkIAmKWSJ3tkwkDGAXDO98kEIGIBQPp-SI667mOgZBSxCVn9_gRX9hN9UyN9QmfbEp2u6ANuXNNqX_YXdD6jzxtde-u1t1uk941ry2aN3llDs1pXfYcdbQqafTdDopkfVsue6jqnL19YVbZeHZODQlcdnvzPKXm7uX69vAsWj7fzy2wRYMiZD8IUlzziEhIQMk5EAixdJhGaUGqjhzelCAsNMo8LQCZYXmAaM2ZEgolIC8Gn5Gx3t9Wd0VXhdG1sp1pn19r1ikXAQaQDlu4wHLpsLTrVGYu1wdw6NF7ljVUM1OhVjV7V6FWNXvkfpCptbA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>γ-Diketone Peripheral Neuropathy: I. Quantitative Morphometric Analyses of Axonal Atrophy and Swelling</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lehning, Ellen J. ; Jortner, Bernard S. ; Fox, Jonathan H. ; Arezzo, Joseph C. ; Kitano, Taka-aki ; LoPachin, Richard M.</creator><creatorcontrib>Lehning, Ellen J. ; Jortner, Bernard S. ; Fox, Jonathan H. ; Arezzo, Joseph C. ; Kitano, Taka-aki ; LoPachin, Richard M.</creatorcontrib><description>Quantitative morphometric analysis was used to characterize expression of myelinated axon swelling and atrophy in rat peripheral nerve during 2,5-hexanedione (HD) intoxication. HD was administered by gavage according to different daily dosing regiments (100, 175, 250, or 400 mg/kg/day) and four proximodistal nerve regions (5th lumbar spinal nerve, proximal and distal sciatic nerve, and tibial nerve) were examined morphometrically. Morphometric determinations were made at four behavioral endpoints (unaffected, slight, moderate, and severe toxicity) and were correlated to electrophysiologic measurements of peripheral nerve function. Results show that, for all HD dose rates, onsets of behavioral neurotoxicity and nerve dysfunction were generally related to development of abundant axon atrophy. The proximodistal manifestation of atrophy was dependent upon the dosing rate; i.e., the atrophy response produced by subacute intoxication with higher daily dosing rates (250 and 400 mg/kg/day) was restricted to distal nerve regions whereas subchronic induction with lower dosing rates (100 and175 mg/kg/day) produced abundant fiber atrophy in all proximodistal areas. In contrast to atrophy, axonal swellings constituted an inconsistent minor morphologic response, the expression of which was dependent upon subchronic dosing rates (100–250 mg/kg/day). Subacute HD administration (400 mg/kg/day) produced significant changes in neurobehavior and nerve electrophysiologic parameters in the absence of peripheral axon swelling. Thus, conditional expression of swellings suggests they are an epiphenomenon related to low-dose induction rates. Fiber atrophy, however, was numerically dominant, correlated with nerve dysfunction, and occurred at all dosing levels. These characteristics suggest atrophy is a neurotoxicologically significant feature of γ-diketone peripheral neuropathy.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1006/taap.2000.8937</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Biological and medical sciences ; Chemical and industrial products toxicology. Toxic occupational diseases ; Medical sciences ; Solvents ; Toxicology</subject><ispartof>Toxicology and applied pharmacology, 2000-06, Vol.165 (2), p.127-140</ispartof><rights>2000 Academic Press</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X00989373$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1403058$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Lehning, Ellen J.</creatorcontrib><creatorcontrib>Jortner, Bernard S.</creatorcontrib><creatorcontrib>Fox, Jonathan H.</creatorcontrib><creatorcontrib>Arezzo, Joseph C.</creatorcontrib><creatorcontrib>Kitano, Taka-aki</creatorcontrib><creatorcontrib>LoPachin, Richard M.</creatorcontrib><title>γ-Diketone Peripheral Neuropathy: I. Quantitative Morphometric Analyses of Axonal Atrophy and Swelling</title><title>Toxicology and applied pharmacology</title><description>Quantitative morphometric analysis was used to characterize expression of myelinated axon swelling and atrophy in rat peripheral nerve during 2,5-hexanedione (HD) intoxication. HD was administered by gavage according to different daily dosing regiments (100, 175, 250, or 400 mg/kg/day) and four proximodistal nerve regions (5th lumbar spinal nerve, proximal and distal sciatic nerve, and tibial nerve) were examined morphometrically. Morphometric determinations were made at four behavioral endpoints (unaffected, slight, moderate, and severe toxicity) and were correlated to electrophysiologic measurements of peripheral nerve function. Results show that, for all HD dose rates, onsets of behavioral neurotoxicity and nerve dysfunction were generally related to development of abundant axon atrophy. The proximodistal manifestation of atrophy was dependent upon the dosing rate; i.e., the atrophy response produced by subacute intoxication with higher daily dosing rates (250 and 400 mg/kg/day) was restricted to distal nerve regions whereas subchronic induction with lower dosing rates (100 and175 mg/kg/day) produced abundant fiber atrophy in all proximodistal areas. In contrast to atrophy, axonal swellings constituted an inconsistent minor morphologic response, the expression of which was dependent upon subchronic dosing rates (100–250 mg/kg/day). Subacute HD administration (400 mg/kg/day) produced significant changes in neurobehavior and nerve electrophysiologic parameters in the absence of peripheral axon swelling. Thus, conditional expression of swellings suggests they are an epiphenomenon related to low-dose induction rates. Fiber atrophy, however, was numerically dominant, correlated with nerve dysfunction, and occurred at all dosing levels. These characteristics suggest atrophy is a neurotoxicologically significant feature of γ-diketone peripheral neuropathy.</description><subject>Biological and medical sciences</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Medical sciences</subject><subject>Solvents</subject><subject>Toxicology</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNotkMtOwzAQRS0EEqWwZe0F25RxHCcxu4hnpfISILGzXGfSGNIkctxCvov_4JtIVFajK50Z3TmEnDKYMYD43GvdzkIAmKWSJ3tkwkDGAXDO98kEIGIBQPp-SI667mOgZBSxCVn9_gRX9hN9UyN9QmfbEp2u6ANuXNNqX_YXdD6jzxtde-u1t1uk941ry2aN3llDs1pXfYcdbQqafTdDopkfVsue6jqnL19YVbZeHZODQlcdnvzPKXm7uX69vAsWj7fzy2wRYMiZD8IUlzziEhIQMk5EAixdJhGaUGqjhzelCAsNMo8LQCZYXmAaM2ZEgolIC8Gn5Gx3t9Wd0VXhdG1sp1pn19r1ikXAQaQDlu4wHLpsLTrVGYu1wdw6NF7ljVUM1OhVjV7V6FWNXvkfpCptbA</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>Lehning, Ellen J.</creator><creator>Jortner, Bernard S.</creator><creator>Fox, Jonathan H.</creator><creator>Arezzo, Joseph C.</creator><creator>Kitano, Taka-aki</creator><creator>LoPachin, Richard M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>20000601</creationdate><title>γ-Diketone Peripheral Neuropathy: I. Quantitative Morphometric Analyses of Axonal Atrophy and Swelling</title><author>Lehning, Ellen J. ; Jortner, Bernard S. ; Fox, Jonathan H. ; Arezzo, Joseph C. ; Kitano, Taka-aki ; LoPachin, Richard M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e231t-28eb3439070596757018b74ec29aca100952fa09d6f0e151dfe8611c57e758f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Biological and medical sciences</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Medical sciences</topic><topic>Solvents</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lehning, Ellen J.</creatorcontrib><creatorcontrib>Jortner, Bernard S.</creatorcontrib><creatorcontrib>Fox, Jonathan H.</creatorcontrib><creatorcontrib>Arezzo, Joseph C.</creatorcontrib><creatorcontrib>Kitano, Taka-aki</creatorcontrib><creatorcontrib>LoPachin, Richard M.</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lehning, Ellen J.</au><au>Jortner, Bernard S.</au><au>Fox, Jonathan H.</au><au>Arezzo, Joseph C.</au><au>Kitano, Taka-aki</au><au>LoPachin, Richard M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>γ-Diketone Peripheral Neuropathy: I. Quantitative Morphometric Analyses of Axonal Atrophy and Swelling</atitle><jtitle>Toxicology and applied pharmacology</jtitle><date>2000-06-01</date><risdate>2000</risdate><volume>165</volume><issue>2</issue><spage>127</spage><epage>140</epage><pages>127-140</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>Quantitative morphometric analysis was used to characterize expression of myelinated axon swelling and atrophy in rat peripheral nerve during 2,5-hexanedione (HD) intoxication. HD was administered by gavage according to different daily dosing regiments (100, 175, 250, or 400 mg/kg/day) and four proximodistal nerve regions (5th lumbar spinal nerve, proximal and distal sciatic nerve, and tibial nerve) were examined morphometrically. Morphometric determinations were made at four behavioral endpoints (unaffected, slight, moderate, and severe toxicity) and were correlated to electrophysiologic measurements of peripheral nerve function. Results show that, for all HD dose rates, onsets of behavioral neurotoxicity and nerve dysfunction were generally related to development of abundant axon atrophy. The proximodistal manifestation of atrophy was dependent upon the dosing rate; i.e., the atrophy response produced by subacute intoxication with higher daily dosing rates (250 and 400 mg/kg/day) was restricted to distal nerve regions whereas subchronic induction with lower dosing rates (100 and175 mg/kg/day) produced abundant fiber atrophy in all proximodistal areas. In contrast to atrophy, axonal swellings constituted an inconsistent minor morphologic response, the expression of which was dependent upon subchronic dosing rates (100–250 mg/kg/day). Subacute HD administration (400 mg/kg/day) produced significant changes in neurobehavior and nerve electrophysiologic parameters in the absence of peripheral axon swelling. Thus, conditional expression of swellings suggests they are an epiphenomenon related to low-dose induction rates. Fiber atrophy, however, was numerically dominant, correlated with nerve dysfunction, and occurred at all dosing levels. These characteristics suggest atrophy is a neurotoxicologically significant feature of γ-diketone peripheral neuropathy.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><doi>10.1006/taap.2000.8937</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2000-06, Vol.165 (2), p.127-140
issn 0041-008X
1096-0333
language eng
recordid cdi_pascalfrancis_primary_1403058
source ScienceDirect Journals (5 years ago - present)
subjects Biological and medical sciences
Chemical and industrial products toxicology. Toxic occupational diseases
Medical sciences
Solvents
Toxicology
title γ-Diketone Peripheral Neuropathy: I. Quantitative Morphometric Analyses of Axonal Atrophy and Swelling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T17%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B3-Diketone%20Peripheral%20Neuropathy:%20I.%20Quantitative%20Morphometric%20Analyses%20of%20Axonal%20Atrophy%20and%20Swelling&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Lehning,%20Ellen%20J.&rft.date=2000-06-01&rft.volume=165&rft.issue=2&rft.spage=127&rft.epage=140&rft.pages=127-140&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1006/taap.2000.8937&rft_dat=%3Celsevier_pasca%3ES0041008X00989373%3C/elsevier_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0041008X00989373&rfr_iscdi=true